Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ovid Therapeutics Inc. buy Lokrim

Ovid Therapeutics Inc.
Start price
€1.17
29.09.25 / 20%
Target price
-
29.09.26
Performance (%)
22.22%
End price
€1.43
10.10.25
Summary
This prediction ended on 10.10.25 with a price of €1.43. The BUY prediction by Lokrim finished with a performance of 22.22%. Lokrim has a follow-up prediction for Ovid Therapeutics Inc. where he still thinks Ovid Therapeutics Inc. is a Buy. Lokrim has 20% into this prediction
Performance without dividends (%)
Name 1w 1m
Ovid Therapeutics Inc. - -
iShares Core DAX® 2.462% 4.579%
iShares Nasdaq 100 1.237% -0.442%
iShares Nikkei 225® 2.933% 1.229%
iShares S&P 500 0.975% 0.565%

According to Lokrim what are the pros and cons of Ovid Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by Lokrim for this prediction

In the thread Ovid Therapeutics Inc. diskutieren

Buy Ovid Therapeutics Inc.

Lokrim 
0
Report Share
29.09.25 Buy 22.22%
In the thread Trading Ovid Therapeutics Inc.
Prediction Buy
Perf. (%) 22.22%
Target price
Change
Ends at 29.09.26

Buy beendet

Lokrim 
0
Report Share
10.10.25

Current prediction by Lokrim for Ovid Therapeutics Inc.

buy
Ovid Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.53
04.01.26
-
04.01.27
0.00%
07.01.26

Could be worthwhile Investment >10% per year
Lokrim 
04.01.26 20%